1. Home
  2. HITI vs ALLO Comparison

HITI vs ALLO Comparison

Compare HITI & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HITI
  • ALLO
  • Stock Information
  • Founded
  • HITI 2009
  • ALLO 2017
  • Country
  • HITI Canada
  • ALLO United States
  • Employees
  • HITI N/A
  • ALLO N/A
  • Industry
  • HITI
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • HITI
  • ALLO Health Care
  • Exchange
  • HITI Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • HITI 257.8M
  • ALLO 252.9M
  • IPO Year
  • HITI N/A
  • ALLO 2018
  • Fundamental
  • Price
  • HITI $2.73
  • ALLO $1.24
  • Analyst Decision
  • HITI Strong Buy
  • ALLO Buy
  • Analyst Count
  • HITI 2
  • ALLO 11
  • Target Price
  • HITI $6.13
  • ALLO $8.67
  • AVG Volume (30 Days)
  • HITI 459.0K
  • ALLO 2.4M
  • Earning Date
  • HITI 09-15-2025
  • ALLO 11-06-2025
  • Dividend Yield
  • HITI N/A
  • ALLO N/A
  • EPS Growth
  • HITI N/A
  • ALLO N/A
  • EPS
  • HITI N/A
  • ALLO N/A
  • Revenue
  • HITI $410,600,094.00
  • ALLO N/A
  • Revenue This Year
  • HITI $14.07
  • ALLO N/A
  • Revenue Next Year
  • HITI $29.67
  • ALLO $100.00
  • P/E Ratio
  • HITI N/A
  • ALLO N/A
  • Revenue Growth
  • HITI 11.18
  • ALLO N/A
  • 52 Week Low
  • HITI $1.64
  • ALLO $0.86
  • 52 Week High
  • HITI $4.06
  • ALLO $3.78
  • Technical
  • Relative Strength Index (RSI)
  • HITI 29.68
  • ALLO 52.74
  • Support Level
  • HITI $2.83
  • ALLO $1.15
  • Resistance Level
  • HITI $3.03
  • ALLO $1.28
  • Average True Range (ATR)
  • HITI 0.10
  • ALLO 0.08
  • MACD
  • HITI -0.02
  • ALLO 0.01
  • Stochastic Oscillator
  • HITI 0.88
  • ALLO 74.07

About HITI High Tide Inc.

High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, Famous Brandz, and others. The company's reportable operating segments are; Bricks and mortar which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada followed by the United States of America, and other international markets.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: